CYTH — Cyclo Therapeutics Share News
0.000.00%
Last trade - 00:00- $23.04m
- $34.29m
- $1.08m
Cyclo Therapeutics Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Cyclo Therapeutics Inc Issues $2.5 Million Convertible Promissory Note To Rafael Holdings
U.S. STOCKS ON THE MOVE-McDonald, Uber, SolarWinds
Cyclo Therapeutics jumps on prelim late-stage data of genetic disorder drug
Brief: Cyclo Therapeutics Presents Positive Preliminary Data from Ongoing Phase 3 TransportNPC™ Open-Label Sub-Study in Patients (< 3 Years Old)
Cyclo Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Cyclo Therapeutics Entered Into A Fifth Amended And Restated Note Purchase Agreement
Brief: Pacira Biosciences Appoints Shawn Cross As Chief Financial Officer
Brief: Cyclo Therapeutics Says Entered Into A Fourth Amended And Restated Note Purchase Agreement With Rafael Holdings
Brief: Cyclo Therapeutics Presents Encouraging Preliminary Safety Data From Ongoing Pivotal Phase 3 Study And Substudy For The Treatment Of Niemann-Pick Disease Type C1 (Npc1)
U.S. STOCKS ON THE MOVE-NetEase, Wolfspeed, B. Riley
U.S. STOCKS ON THE MOVE-Evogene, Stryker, Opera
Cyclo Therapeutics falls after merger agreement with Rafael Holdings
U.S. STOCKS ON THE MOVE-Snowflake, Zoom, Synopsys
U.S. STOCKS ON THE MOVE-Wolfspeed, Synopsys, Zuora
Brief: Rafael Holdings And Cyclo Therapeutics Enter Into A Definitive Merger Agreement
Cyclo Therapeutics falls after merger agreement with Rafael Holdings
Cyclo Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Cyclo Therapeutics Inc expected to post a loss of 15 cents a share - Earnings Preview